(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Crystal Gateway Marriott

Sep 23, 2026 8:15 AM - Sep 25, 2026 12:45 PM

1700 Richmond Highway, Arlington, VA 22202, USA

Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

Register
Early Bird Ends

DAYS

HOURS

MINUTES

SECONDS

Back to Agenda

Session 3 Tracks 1 and 2: Regulatory Considerations of Novel Conjugates: Translational and Clinical Pharmacology Perspectives

Session Chair(s)

Louis St. L. O'Dea, MD

Louis St. L. O'Dea, MD

Independent Consultant, United States

Patrik Andersson, PHD

Patrik Andersson, PHD

Principal Scientist, Discovery Safety Specialist, AstraZeneca R&D, Sweden

Session 3 Tracks 1 and 2: Regulatory Considerations of Novel Conjugates: Translational and Clinical Pharmacology Perspectives

Have an account?

Register

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.